Therapeutic drug monitoring in antituberculosis chemotherapy: clinical perspectives

Authors
Citation
Ww. Yew, Therapeutic drug monitoring in antituberculosis chemotherapy: clinical perspectives, CLIN CHIM A, 313(1-2), 2001, pp. 31-36
Citations number
38
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
CLINICA CHIMICA ACTA
ISSN journal
00098981 → ACNP
Volume
313
Issue
1-2
Year of publication
2001
Pages
31 - 36
Database
ISI
SICI code
0009-8981(200111)313:1-2<31:TDMIAC>2.0.ZU;2-#
Abstract
Background: Therapeutic drug monitoring (TDM) represents an area where mult idisciplinary service is rendered for optimization of clinical care, throug h enabling maximum drug therapeutic efficacy and minimum drug toxicity. Thi s is a recently developed field for antituberculosis chemotherapy. The othe r goals of TDM principally include study and management of pharmacokinetic drug-drug and drug-disease interactions as well as the evaluation of new fi xed-dose combinations (FDC) developed for treatment of tuberculosis. Conclu sion: In the years to come, with the advancement in knowledge. technology a nd expertise, it is hoped that TDM, as a novel paradigm of care in tubercul osis, may gain expanding indications and reach a new horizon. (C) 2001 Else vier Science B.V. All rights reserved.